SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 52 filers reported holding SIO GENE THERAPIES INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -99.9% | 15,453 | -59.7% | 0.00% | – |
| Q3 2022 | $11,000 | -15.4% | 38,306 | +9.4% | 0.00% | – |
| Q2 2022 | $13,000 | +116.7% | 35,014 | +323.8% | 0.00% | – |
| Q1 2022 | $6,000 | -62.5% | 8,262 | -31.6% | 0.00% | – |
| Q4 2021 | $16,000 | -20.0% | 12,073 | +30.3% | 0.00% | -100.0% |
| Q3 2021 | $20,000 | – | 9,262 | +9070.3% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 101 | -97.5% | 0.00% | – |
| Q1 2021 | $11,000 | -78.4% | 4,079 | -77.7% | 0.00% | -100.0% |
| Q4 2020 | $51,000 | – | 18,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,969,987 | $8,108,000 | 0.98% |
| Opaleye Management Inc. | 2,000,000 | $5,258,000 | 0.87% |
| Rubric Capital Management LP | 3,000,000 | $8,190,000 | 0.52% |
| Prosight Management, LP | 256,115 | $699,000 | 0.44% |
| ACT CAPITAL MANAGEMENT, LLC | 185,000 | $506,000 | 0.26% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,985,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 363,887 | $993,000 | 0.11% |
| KNOTT DAVID M | 80,000 | $218,000 | 0.08% |
| Hudson Bay Capital Management LP | 1,540,000 | $4,204,000 | 0.05% |
| APOGEM CAPITAL LLC | 19,401 | $53,000 | 0.03% |